Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes.
Currently, the clinical use of 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX) for photodynamic therapy (PDT) is limited by the maximum tolerated oral ALA dose (60 mg/kg). Attempts have been made to enhance this treatment modality without increasing the administered dose of ALA. One way to do this is through light dose fractionation, where the irradiation is interrupted at a particular point for a short period of time. This can produce up to three times more necrosis than with the same light dose delivered without a break. An oxygen microelectrode was employed to study the effect of continuous and fractionated light regimes on the level of oxygen in the colon of normal Wistar rats during ALA PDT. A rapid decline in pO2 occurred close to the irradiation fibre as soon as the light dose commenced. With the fractionated regime, a partial recovery in pO2 was observed during the dark interval which was reversed soon after the second light fraction commenced. We have shown that the level of tissue oxygen at the treatment site is affected differently when the light dose is fractionated, than when continuous illumination is employed. This factor may at least partially explain the difference in outcome of these two treatment regimes. Further, oxygen measurements might prove to be a useful way of monitoring PDT treatments if they can predict whether tissue is likely to be viable following treatment.
Curnow
A
A
National Medical Laser Centre, Institute of Surgical Studies, Royal Free and University College Medical School, University College London, UK. a.curnow@tesco.net
Haller
J C
JC
Bown
S G
SG
D000622:Aminolevulinic Acid / Q000008:administration & dosage / Q000378:metabolism / Q000528:radiation effects; D000818:Animals; D003106:Colon / Q000187:drug effects* / Q000378:metabolism* / Q000528:radiation effects; D005260:Female; D008027:Light; D008991:Monitoring, Physiologic; D009336:Necrosis; D010100:Oxygen / Q000032:analysis / Q000378:metabolism*; D018462:Photobiology; D010778:Photochemotherapy; D011524:Protoporphyrins; D051381:Rats; D017208:Rats, Wistar
D011524:Protoporphyrins; D000622:Aminolevulinic Acid; C028025:protoporphyrin IX; D010100:Oxygen